Treatment of type 2 diabetes in the elderly
- PMID: 22484911
- DOI: 10.1007/s11892-012-0269-4
Treatment of type 2 diabetes in the elderly
Abstract
As the number of older adults increases in the United States and worldwide, management of patients with multiple coexisting chronic diseases has become a critical component in health care. Management of diabetes is particularly challenging in this population due to significant risks of microvascular and macrovascular diseases on the one hand, and complications of the treatment strategies (e.g., hypoglycemia) with intensive control on the other hand. To provide a balanced approach to diabetes in the elderly, a comprehensive and holistic strategy, with consideration of overall health, functional status, psychosocial environment, financial resources and, finally but most importantly, quality of life is needed. Understanding the unique challenges faced by older adults with diabetes and issues pertaining to antidiabetes medications with aging is an important first step in the direction of better and tailored care of this burgeoning population.
Similar articles
-
Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.Can J Diabetes. 2018 Aug;42(4):365-371.e2. doi: 10.1016/j.jcjd.2017.08.248. Epub 2017 Oct 13. Can J Diabetes. 2018. PMID: 29037572
-
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1671-1690. doi: 10.1016/j.numecd.2021.02.029. Epub 2021 Mar 6. Nutr Metab Cardiovasc Dis. 2021. PMID: 33994263 Review.
-
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.J Cardiometab Syndr. 2006 Fall;1(5):358-61. doi: 10.1111/j.1559-4564.2006.06035.x. J Cardiometab Syndr. 2006. PMID: 17679795 No abstract available.
-
Medication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvement.Curr Cardiol Rep. 2013 Nov;15(11):418. doi: 10.1007/s11886-013-0418-7. Curr Cardiol Rep. 2013. PMID: 24057772 Review.
-
Glucose and LDL lowering: the need for intensive therapy.Curr Vasc Pharmacol. 2012 Nov;10(6):687-9. doi: 10.2174/157016112803520792. Curr Vasc Pharmacol. 2012. PMID: 23259554 Review.
Cited by
-
Efficacy of a New Medical Information system, Ubiquitous Healthcare Service with Voice Inception Technique in Elderly Diabetic Patients.Sci Rep. 2015 Dec 11;5:18214. doi: 10.1038/srep18214. Sci Rep. 2015. PMID: 26658492 Free PMC article.
-
Economic costs and medications for diabetes in older patients in Beijing, China: electronic insurance data analysis.Front Pharmacol. 2025 Apr 7;16:1549244. doi: 10.3389/fphar.2025.1549244. eCollection 2025. Front Pharmacol. 2025. PMID: 40260392 Free PMC article.
-
Global trends and hotspots in blood glucose management for elderly patients with diabetes: A bibliometric analysis (2000-2024).Medicine (Baltimore). 2025 Aug 15;104(33):e43919. doi: 10.1097/MD.0000000000043919. Medicine (Baltimore). 2025. PMID: 40826688 Free PMC article.
-
Hospitalization of elderly diabetic patients: characteristics, reasons for admission, and gender differences.BMC Geriatr. 2016 Sep 5;16:160. doi: 10.1186/s12877-016-0333-z. BMC Geriatr. 2016. PMID: 27595573 Free PMC article.
-
Dose and time-response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: A randomized, crossover, double-blind, sham-controlled trial.J Biophotonics. 2023 Oct;16(10):e202300083. doi: 10.1002/jbio.202300083. Epub 2023 Jun 27. J Biophotonics. 2023. PMID: 37171054 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials